Ryvu Therapeutics sums up achievements of H1 2020

Ryvu Therapeutics, one of the largest innovative biotechnology companies in Europe, operating in the field of discovering and developing new oncological therapies, reported in the first half of this year 38 percent increase in revenues to PLN 24.5 million (including PLN 14.7 million from partnering agreements.) The company summarized the progress in scientific projects, key activities and events taking place in the reporting period.

“In our organization, we are used to…